Rakovina Therapeutics Inc. (TSXV:RKV), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies, presented at the American Association of Cancer Research Annual Meeting. The AACR Annual Meeting, held from April 8th to 13th in New Orleans, is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine.
top of page
Recent Posts
See AllThe Company has entered into a Marketing Services Agreement dated September 22, 2023 with Octagon Media Corp.
Visionstate continues to make strides in improving operational efficiency and cleanliness in various sectors.
Fabrice brings 3 decades of extensive IT knowledge, expertise and an 11-year track record as a trailblazer in the digital health sector.
© 2023 Frontier Merchant Capital Group. All Rights Reserved.
bottom of page